Skip to main content
. 2019 Oct 18;1(6):366–375. doi: 10.1016/j.xkme.2019.07.015

Figure 2.

Figure 2

Changes in median kidney volume after sclerotherapy. There was a 21.8% (249 mL) decrease in targeted kidney volume (n = 95; P<0.001) and 3.4% increase (22 mL) in nontargeted kidney volume (n = 37; P<0.001). Mean interval between magnetic resonance imaging scans pre- and postsclerotherapy was 13.6 ± 4.9 (standard deviation) months.